H. Konaka

发表

Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles.

Yusuke Nakamura, Tatsuhiko Tsunoda, Hidewaki Nakagawa, 2007, Cancer research.

Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system

S. Ogawa, M. Egawa, Y. Kitagawa, 2003, The journal of gene medicine.

Therapies for castration‐resistant prostate cancer in a new era: The indication of vintage hormonal therapy, chemotherapy and the new medicines

K. Izumi, Y. Kitagawa, A. Mizokami, 2017, International journal of urology : official journal of the Japanese Urological Association.

Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study

T. Iwamoto, H. Origasa, A. Mizokami, 2011, The aging male : the official journal of the International Society for the Study of the Aging Male.

Impact of PSA levels on second-round screening for the development of prostate cancer in men with low baseline PSA levels (≤2.0 mg/ml).

K. Izumi, Y. Kitagawa, A. Mizokami, 2014, Anticancer research.

Title Chronological urodynamic evaluation of changing bladder and urethralfunctions after robot-assisted radical prostatectomy

K. Izumi, Y. Kitagawa, A. Mizokami, 2017 .

S&T-20 VALIDATION OF TNM CLASSIFICATION FOR METASTATIC PROSTATIC CANCER TREATED USING PRIMARY ANDROGEN DEPRIVATION THERAPY

H. Akaza, K. Izumi, Y. Kitagawa, 2016 .

Validation of TNM classification for metastatic prostatic cancer treated using primary androgen deprivation therapy

H. Akaza, K. Izumi, Y. Kitagawa, 2016, World Journal of Urology.

Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma.

K. Izumi, Y. Kitagawa, A. Mizokami, 2016, Anticancer research.

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan

H. Yaegashi, K. Nakashima, K. Izumi, 2014, Asian journal of andrology.

A sensitive immunochromatographic assay using gold nanoparticles for the semiquantitative detection of prostate-specific antigen in serum

E. Tamiya, Y. Takamura, K. Kerman, 2006 .

The correlation between highly sensitive C-reactive protein levels and erectile function among men with late-onset hypogonadism

Y. Kitagawa, A. Mizokami, M. Namiki, 2016, The aging male : the official journal of the International Society for the Study of the Aging Male.

Exogenous SPARC Suppresses Proliferation and Migration of Prostate Cancer by Interacting With Integrin β1

E. Keller, Y. Kitagawa, A. Mizokami, 2013, The Prostate.

Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study)

K. Nakashima, T. Iwamoto, Y. Kitagawa, 2017, The aging male : the official journal of the International Society for the Study of the Aging Male.

Effects of testosterone replacement therapy on nocturia and quality of life in men with hypogonadism: a subanalysis of a previous prospective randomized controlled study in Japan

T. Iwamoto, Y. Kitagawa, A. Mizokami, 2015, The aging male : the official journal of the International Society for the Study of the Aging Male.

Lower Urinary Tract Symptoms are Associated with Erectile Function and Psychological Symptoms in Men with Late‐Onset Hypogonadism Syndrome

Y. Kitagawa, A. Mizokami, M. Namiki, 2014, Lower urinary tract symptoms.

Effects of dutasteride on lower urinary tract symptoms and general health in men with benign prostatic hypertroplasia and hypogonadism: a prospective study

H. Yaegashi, Y. Kitagawa, A. Mizokami, 2014, The aging male : the official journal of the International Society for the Study of the Aging Male.

Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus

K. Nakashima, K. Izumi, A. Mizokami, 2018, International Journal of Impotence Research.

Oxidative Stress Induces ADAM 9 Protein Expression in Human Prostate Cancer Cells

F. Marshall, M. Amin, L. Chung, 2006 .

The relationship of serum and salivary cortisol levels to male sexual dysfunction as measured by the International Index of Erectile Function

T. Iwamoto, A. Mizokami, M. Namiki, 2009, International Journal of Impotence Research.

Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice

K. Izumi, Y. Kitagawa, A. Mizokami, 2016, Asian journal of andrology.

Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.

L. Chung, M. Freeman, M. Mayo, 2004, The Biochemical journal.

Prospective longitudinal comparative study of health-related quality of life and treatment satisfaction in patients treated with hormone therapy, radical retropubic prostatectomy, and high or low dose rate brachytherapy for prostate cancer

Y. Kitagawa, A. Mizokami, M. Namiki, 2013, Prostate international.

Relationship between tumor-infiltrating T lymphocytes and clinical response after reduced-intensity allogeneic hematopoietic stem cell transplantation for advanced renal cell carcinoma: a single center prospective study.

K. Ishiyama, M. Namiki, Shioto Suzuki, 2009, Japanese journal of clinical oncology.

The effectiveness of interferon-alpha subtypes alternation for metastasis from renal cell carcinoma.

A. Mizokami, M. Namiki, A. Hirata, 2012, Biomedical research.

Myelodysplastic syndrome treated effectively with testosterone enanthate

A. Mizokami, M. Namiki, K. Shigehara, 2011, International journal of urology : official journal of the Japanese Urological Association.

Cumulative probability of prostate cancer detection using the international prostate symptom score in a prostate-specific antigen-based population screening program in Japan.

K. Izumi, Y. Kitagawa, A. Mizokami, 2014, Asian Pacific journal of cancer prevention : APJCP.

Selection of adjuvant intravesical therapies using the European Organization for Research and Treatment of Cancer scoring system in patients at intermediate risk of non-muscle-invasive bladder cancer

H. Yaegashi, K. Izumi, Y. Kitagawa, 2014, Journal of Cancer Research and Clinical Oncology.

Postoperative voiding function in patients undergoing tension-free vaginal mesh procedure for pelvic organ prolapse

Y. Kitagawa, M. Namiki, K. Narimoto, 2011, International Urogynecology Journal.

The correlation between erectile function and adiponectin levels in men with late-onset hypogonadism

K. Izumi, A. Mizokami, M. Namiki, 2022, The aging male : the official journal of the International Society for the Study of the Aging Male.

Repression of cell proliferation and androgen receptor activity in prostate cancer cells by 2'-hydroxyflavanone.

Jian Zhang, E. Keller, K. Izumi, 2013, Anticancer research.

SHORT-TERM EFFECTS OF TESTOSTERONE REPLACEMENT THERAPY ON RISK PREDICTORS FOR ARTERIOSCLEROSIS AMONG MEN WITH LATE-ONSET HYPOGONADISM: A CASE–CONTROL STUDY

K. Izumi, A. Mizokami, M. Namiki, 2020 .

SOD3 acts as a tumor suppressor in PC-3 prostate cancer cells via hydrogen peroxide accumulation.

Jian Zhang, E. Keller, K. Izumi, 2014, Anticancer research.

Editorial Comment to Endocrinological and symptomatic characteristics of patients with late‐onset hypogonadism classified by functional categories based on testosterone and luteinizing hormone levels

H. Konaka, 2020, International journal of urology : official journal of the Japanese Urological Association.

Immunolocalization of anti-placental alkaline phosphatase monoclonal antibody in mice with testicular tumors and lymph node metastasis

K. Hirano, K. Yokoyama, M. Namiki, 1999, Urological Research.

Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: role of cAMP-dependent protein kinase A signaling pathway.

L. Chung, Zhihui Xie, H. Zhau, 2005, Cancer research.

cAMP-Dependent Protein Kinase A Signaling Pathway Osteomimicry of Prostate Cancer Cells : Role of Human Osteocalcin and Bone Sialoprotein Mediating

L. Chung, Zhihui Xie, H. Zhau, 2005 .

Label-free bioelectronic immunoassay for the detection of human telomerase reverse transcriptase in urine

Kagan Kerman, Eiichi Tamiya, Naoki Nagatani, 2006 .

Resin-based micropipette tip for immunochromatographic assays in urine samples.

E. Tamiya, Y. Takamura, K. Kerman, 2006, Journal of immunological methods.

Etiological role of human papillomavirus infection for inverted papilloma of the bladder

T. Sasagawa, J. Doorbar, Y. Kitagawa, 2011, Journal of medical virology.

Ethinylestradiol improves prostate-specific antigen levels in pretreated castration-resistant prostate cancer patients.

K. Izumi, A. Mizokami, M. Namiki, 2010, Anticancer research.

Oxidative stress induces ADAM9 protein expression in human prostate cancer cells.

F. Marshall, M. Amin, L. Chung, 2006, Cancer research.

Preliminary results of tranilast treatment for patients with advanced castration-resistant prostate cancer.

K. Izumi, A. Mizokami, M. Namiki, 2010, Anticancer research.

Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor β1‐associated osteoblastic changes

E. Keller, K. Izumi, Y. Kitagawa, 2009, The Prostate.

Etiologic role of human papillomavirus infection in bladder carcinoma

T. Sasagawa, A. Mizokami, M. Namiki, 2011, Cancer.

The relationship between prostate‐specific antigen and TNM classification or Gleason score in prostate cancer patients with low prostate‐specific antigen levels

H. Ikeda, K. Izumi, Y. Kitagawa, 2015, The Prostate.

Changes in penile length after radical prostatectomy: investigation of the underlying anatomical mechanism

K. Nakashima, K. Izumi, Y. Kitagawa, 2017, BJU international.

Gold nanoparticle based immunochromatography using a resin modified micropipette tip for rapid and simple detection of human chorionic gonadotropin hormone and prostate-specific antigen

Tatsuro Endo, Yuzuru Takamura, Kagan Kerman, 2006 .

Comparison of two in vivo models for prostate cancer: Orthotopic and intratesticular inoculation of LNCaP or PC‐3 cells

M. Egawa, A. Mizokami, M. Namiki, 2004, International journal of urology : official journal of the Japanese Urological Association.

A case of bone, lung, pleural and liver metastases from renal cell carcinoma which responded remarkably well to zoledronic acid monotherapy.

K. Izumi, A. Mizokami, M. Namiki, 2009, Japanese journal of clinical oncology.

Severe Renal Hemorrhage in a Pregnant Woman Complicated with Antiphospholipid Syndrome: A Case Report

K. Izumi, A. Mizokami, M. Namiki, 2011, Advances in urology.

Prevalence of genital Mycoplasma, Ureaplasma, Gardnerella, and human papillomavirus in Japanese men with urethritis, and risk factors for detection of urethral human papillomavirus infection

T. Sasagawa, A. Mizokami, M. Namiki, 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Differential diagnosis between bacterial infection and neoplastic fever in patients with advanced urological cancer: The role of procalcitonin

H. Yaegashi, K. Izumi, Y. Kitagawa, 2014, International journal of urology : official journal of the Japanese Urological Association.

The role of procalcitonin in differentiation between bacterial infection and neoplastic fever in patients with advanced urological cancer

H. Yaegashi, K. Izumi, Y. Kitagawa, 2014 .

Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal‐related events in patients with prostate cancer with bone metastasis

K. Izumi, A. Mizokami, M. Namiki, 2012, BJU international.

Effects of long-term androgen replacement therapy on the physical and mental statuses of aging males with late-onset hypogonadism: a multicenter, randomized controlled trial in Japan (EARTH Study)

T. Takamura, T. Iwamoto, M. Namiki, 2015, Asian journal of andrology.

Cumulative probability of prostate cancer detection in biopsy according to free/total PSA ratio in men with total PSA levels of 2.1–10.0 ng/ml at population screening

K. Izumi, Y. Kitagawa, A. Mizokami, 2013, Journal of Cancer Research and Clinical Oncology.

Role of Surgical Resection in Adult Urological Soft Tissue Sarcoma: 25-Year Experience

K. Izumi, Y. Kitagawa, A. Mizokami, 2010, Urologia Internationalis.

Simultaneous determination of salivary testosterone and dehydroepiandrosterone using LC-MS/MS: Method development and evaluation of applicability for diagnosis and medication for late-onset hypogonadism.

T. Higashi, A. Mizokami, M. Namiki, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Clinical results of iridium-192 high dose rate brachytherapy with external beam radiotherapy.

K. Izumi, A. Mizokami, M. Namiki, 2010, Japanese journal of clinical oncology.

Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level

Chiung-Kuei Huang, H. Miyamoto, Wen-Jye Lin, 2014, Journal of Cancer Research and Clinical Oncology.

Factors predictive of oncological outcome after nephroureterectomy: comparison between laparoscopic and open procedures.

K. Izumi, Y. Kitagawa, A. Mizokami, 2013, Anticancer research.

Chemotherapy of Metastatic Testicular Germ Cell Tumors: Relationship of Histologic Response to Size Reduction and Changes in Tumor Markers

Y. Kitagawa, M. Namiki, K. Koshida, 1998, International journal of urology : official journal of the Japanese Urological Association.

Aplastic anemia associated with severe hemorrhagic cystitis following radiotherapy for prostate cancer.

K. Izumi, Y. Kitagawa, A. Mizokami, 2016, Molecular and clinical oncology.

Metanephric adenoma treated with laparoscopic nephrectomy: A case report.

H. Ikeda, K. Izumi, A. Mizokami, 2017, Molecular and clinical oncology.

Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.

K. Izumi, Y. Kitagawa, A. Mizokami, 2013, Anticancer research.

Efficacy and Safety of First-Line Cytokines versus Sunitinib and Second-Line Axitinib for Patients with Metastatic Renal Cell Carcinoma (ESCAPE Study): A Phase III, Randomized, Sequential Open-Label Study

S. Anai, N. Kawai, K. Ishibashi, 2023, Cancers.

Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea

A. Mizokami, M. Namiki, K. Shigehara, 2018, The aging male : the official journal of the International Society for the Study of the Aging Male.

Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trial

Hiroyuki Takahashi, N. Stone, S. Egawa, 2012, BMC Cancer.

Preserved renal function after percutaneous radiofrequency ablation for renal tumors: experience of a single institution.

Y. Kitagawa, A. Mizokami, M. Namiki, 2013, Anticancer Research.

Clinicopathological outcomes of clinical T1a renal cell carcinoma by tumor size.

K. Nakashima, K. Izumi, Y. Kitagawa, 2011, Japanese journal of clinical oncology.

Long-term survival following multidisciplinary treatment of metastatic sarcomatoid renal cell carcinoma: a case report

H. Yaegashi, K. Izumi, A. Mizokami, 2015, Journal of Medical Case Reports.

Effects of testosterone replacement therapy on metabolic syndrome among Japanese hypogonadal men: A subanalysis of a prospective randomised controlled trial (EARTH study)

M Namiki, T. Iwamoto, Y. Kitagawa, 2018, Andrologia.

Tranilast InhibitsHormoneRefractory Prostate CancerCell ProliferationandSuppressesTransforming Growth Factor b 1-AssociatedOsteoblastic Changes

E. Keller, K. Izumi, Y. Kitagawa, 2009 .

The five-year effects of testosterone replacement therapy on lipid profile and glucose tolerance among hypogonadal men in Japan: a case control study

K. Nakashima, K. Izumi, A. Mizokami, 2020, The aging male : the official journal of the International Society for the Study of the Aging Male.

Title Outcomes and predictive factors of prostate cancer patients with extremelyhigh prostate-specific antigen level

Chiung-Kuei Huang, H. Miyamoto, K. Izumi, 2017 .

Efficacy and safety of cytokines versus first-line sunitinib and second-line axitinib for patients with metastatic renal cell carcinoma (ESCAPE study): A study protocol for phase III randomized sequential open-label study

S. Anai, N. Kawai, K. Ishibashi, 2019, Contemporary clinical trials communications.

Clinical Features and Treatment Outcomes in Patients with Extragonadal Germ Cell Tumors: A Single-center Experience.

M. Namiki, H. Konaka, T. Makino, 2016, Anticancer Research.

A human seminoma xenograft model with regional lymph node metastasis.

Takuma Sasaki, M. Namiki, K. Koshida, 1999, The Journal of urology.

Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal‐related events in patients with prostate cancer with bone metastasis

K. Izumi, A. Mizokami, M. Namiki, 2012, BJU international.

Tri-modality Therapy with Iodine-125 Brachytherapy, External Beam Radiation Therapy, and Short- or Long-Term Androgen Deprivation Therapy for High-Risk Localized Prostate Cancer: Results of a Multicenter, Randomized Phase 3 Trial (TRIP/TRIGU0907).

T. Momma, H. Konaka, A. Yorozu, 2023, International journal of radiation oncology, biology, physics.

What is appropriate neoadjuvant/adjuvant androgen deprivation for high-risk/locally advanced prostate cancer?

M. Namiki, H. Konaka, 2011, Asian journal of andrology.

Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.

K. Izumi, Y. Kitagawa, A. Mizokami, 2013, Anticancer research.